TRILLIUM THERAPEUTICS INC. Operating Expense
TRILLIUM THERAPEUTICS INC. reported Operating Expense of $35.56 million for the 12-month period ending 2019-12-31, per its 40-F filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2020-03-10
CAD
| Period end | Operating Expense 12 month |
|---|---|
| 2018-12-31 | 47.01M CAD 20-F · filed 2019-03-11 |
| 2017-12-31 | 41.00M CAD 20-F · filed 2019-03-11 |
| 2016-12-31 | 33.72M CAD 40-F · filed 2018-04-04 |
USD
| Period end | Operating Expense 12 month |
|---|---|
| 2019-12-31 | $35.56M 40-F · filed 2020-03-10 |
| 2018-12-31 | $36.37M 40-F · filed 2020-03-10 |